Learn More
Medchemexpress LLC (4-methyl-6-phenylpyridazin-3-yl)-(4-pyrimidin-2-ylpiperazin-1-yl)methanone | 1252608-59-5 | MFCD31544336 | 99.9% | 360.41 g/mol | C20H20N6O | 25 MG

Supplier: Medchemexpress LLC HY10186025MG
GIBH-130 is a small-molecule research compound that inhibits neuroinflammation by suppressing IL-1β secretion from activated microglia (IL-1β IC50 = 3.4 nM). It is orally bioavailable in rodents, shows blood-brain barrier penetration, and has demonstrated in vivo activity in models of cognitive impairment. Supplied as an off-white to pink solid for laboratory research use.
- Potent IL-1β inhibition (IC50 3.4 nM).
- Orally bioavailable with measurable brain penetration in rats.
- Demonstrated efficacy in rodent cognitive-impairment models.
- Also inhibits NO and TNF-α at micromolar concentrations.
- High purity solid, suitable for research applications and formulation studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.